Page 2 - Joshua Copel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nuvo Group Receives 510(k) FDA Clearance for Remote Monitoring of Uterine Activity USA - English News provided by Share this article Share this article TEL AVIV, Israel, June 10, 2021 /PRNewswire/ Nuvo Group a private company commercializing INVU by Nuvo™, an FDA-cleared, patent-protected, prescription-initiated remote pregnancy monitoring platform today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to add a new uterine activity module that provides capability for remote monitoring of uterine activity (UA). With this clearance, INVU can provide a reliable, passive alternative to existing methods of UA measurement. INVU uses only external sensors, allowing it to be used without any invasive component or the need for an in-hospital or in-clinic procedure.

Joshua copelOren ozNuvo groupYale school of medicineYale schoolHealth care amp hospitalsMedical pharmaceuticalsMedical equipmentNew products amp servicesFda approvalQuity amp inclusionஒரேன் ஆஸ்நூவோ குழுயேல் பள்ளி ஆஃப் மருந்துயேல் பள்ளிஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள்